Viewing Study NCT00287859


Ignite Creation Date: 2025-12-24 @ 2:35 PM
Ignite Modification Date: 2026-01-07 @ 8:18 AM
Study NCT ID: NCT00287859
Status: TERMINATED
Last Update Posted: 2017-11-29
First Post: 2006-02-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Topotecan in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Sponsor: Masonic Cancer Center, University of Minnesota
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Fallopian Tube Cancer View
None Ovarian Cancer View
None Peritoneal Cavity Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None fallopian tube cancer View
None peritoneal cavity cancer View
None recurrent ovarian epithelial cancer View